All Insights
Exploring the science, practice, and business of medicine.
Exploring the science, practice, and business of medicine.
Showing 4 out of 4 Insights
HealthSpark, Episode 14: Tisha Boatman, Executive Vice President of External Affairs at Siemens Healthineers, explores how strategic decisions in health technology and delivery can transform markets and patient lives by expanding sustainable access to high-quality care around the world.
The COVID-19 pandemic has led to three key trends in the biopharmaceutical industry: new therapeutic modalities, increased data usage, and stronger collaboration between industry and academia.
Rebecca Miksad, MD, MPH, a senior medical director of Flatiron Health, medical oncologist and health outcomes researcher, discusses how real-world data address regulatory and drug development challenges.
Robert M. Plenge, MD, PhD, senior vice president in research and early development and head of the immunology, cardiovascular, fibrosis, and global health research team at Bristol Myers Squibb, discusses leveraging genetic insights in drug discovery.